172 related articles for article (PubMed ID: 7621583)
41. Effect of steroids on the synthesis of complement C3 in a human alveolar epithelial cell line.
Zach TL; Herrman VA; Hill LD; Leuschen MP
Exp Lung Res; 1993; 19(5):603-16. PubMed ID: 8253061
[TBL] [Abstract][Full Text] [Related]
42. Endothelial cells cultured from human brain microvessels produce complement proteins factor H, factor B, C1 inhibitor, and C4.
Vastag M; Skopál J; Kramer J; Kolev K; Vokó Z; Csonka E; Machovich R; Nagy Z
Immunobiology; 1998 Jul; 199(1):5-13. PubMed ID: 9717663
[TBL] [Abstract][Full Text] [Related]
43. The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 beta (IL-1 beta) and interleukin 1 receptor antagonist (IL-1ra).
Brown EA; Dare HA; Marsh CB; Wewers MD
Cytokine; 1996 Nov; 8(11):828-36. PubMed ID: 9047079
[TBL] [Abstract][Full Text] [Related]
44. Differential modulation of complement factor H and C3 expression by TNF-alpha in the rat. In vitro and in vivo studies.
Julen N; Davrinche C; Ozanne D; Lebreton JP; Fontaine M; Ripoche J; Daveau M
Mol Immunol; 1992; 29(7-8):983-8. PubMed ID: 1386144
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor-beta1 acts as a potent inhibitor of complement C3 biosynthesis in human pancreatic cancer cell lines.
Andoh A; Shimada M; Takaya H; Hata K; Fujiyama Y; Bamba T
Pancreas; 2000 Mar; 20(2):138-45. PubMed ID: 10707928
[TBL] [Abstract][Full Text] [Related]
46. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
[TBL] [Abstract][Full Text] [Related]
47. Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells.
Haselmann J; Goppelt-Struebe M
Cytokine; 1997 Mar; 9(3):199-205. PubMed ID: 9126708
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-6 production in human fibroblasts derived from periodontal tissues is differentially regulated by cytokines and a glucocorticoid.
Okada N; Kobayashi M; Mugikura K; Okamatsu Y; Hanazawa S; Kitano S; Hasegawa K
J Periodontal Res; 1997 Oct; 32(7):559-69. PubMed ID: 9401927
[TBL] [Abstract][Full Text] [Related]
49. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
[TBL] [Abstract][Full Text] [Related]
50. Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro.
Johnson E; Hetland G
Scand J Immunol; 1991 Jun; 33(6):667-71. PubMed ID: 2047760
[TBL] [Abstract][Full Text] [Related]
51. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium.
Her E; Frazer J; Austen KF; Owen WF
J Clin Invest; 1991 Dec; 88(6):1982-7. PubMed ID: 1752957
[TBL] [Abstract][Full Text] [Related]
52. Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium.
Guc D; Gulati P; Lemercier C; Lappin D; Birnie GD; Whaley K
Rheumatol Int; 1993; 13(4):139-46. PubMed ID: 8310205
[TBL] [Abstract][Full Text] [Related]
53. Constitutive and IL 1-regulated murine complement gene expression is strain and tissue specific.
Falus A; Beuscher HU; Auerbach HS; Colten HR
J Immunol; 1987 Feb; 138(3):856-60. PubMed ID: 3492536
[TBL] [Abstract][Full Text] [Related]
54. Dexamethasone inhibits high glucose-, TNF-alpha-, and IL-1beta-induced secretion of inflammatory and angiogenic mediators from retinal microvascular pericytes.
Nehmé A; Edelman J
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2030-8. PubMed ID: 18436837
[TBL] [Abstract][Full Text] [Related]
55. Regulation of acute phase reaction by transforming growth factor beta in cultured murine hepatocytes.
Rokita H; Szuba K
Acta Biochim Pol; 1991; 38(2):241-9. PubMed ID: 1726035
[TBL] [Abstract][Full Text] [Related]
56. Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
Morigi M; Galbusera M; Gastoldi S; Locatelli M; Buelli S; Pezzotta A; Pagani C; Noris M; Gobbi M; Stravalaci M; Rottoli D; Tedesco F; Remuzzi G; Zoja C
J Immunol; 2011 Jul; 187(1):172-80. PubMed ID: 21642543
[TBL] [Abstract][Full Text] [Related]
57. Glucocorticoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanisms.
Zitnik RJ; Whiting NL; Elias JA
Am J Respir Cell Mol Biol; 1994 Jun; 10(6):643-50. PubMed ID: 7516173
[TBL] [Abstract][Full Text] [Related]
58. Recombinant rat IL-1beta and IL-6 synergistically enhance C3 mRNA levels and complement component C3 secretion by H-35 rat hepatoma cells.
Stapp JM; Sjoelund V; Lassiter HA; Feldhoff RC; Feldhoff PW
Cytokine; 2005 Apr; 30(2):78-85. PubMed ID: 15804599
[TBL] [Abstract][Full Text] [Related]
59. Association of glucocorticoids and cyclosporin A or rapamycin prevents E-selectin and IL-8 expression during LPS- and TNFalpha-mediated endothelial cell activation.
Charreau B; Coupel S; Goret F; Pourcel C; Soulillou JP
Transplantation; 2000 Mar; 69(5):945-53. PubMed ID: 10755555
[TBL] [Abstract][Full Text] [Related]
60. Complement C3 production in human intestinal epithelial cells is regulated by interleukin 1beta and tumor necrosis factor alpha.
Moon R; Parikh AA; Szabo C; Fischer JE; Salzman AL; Hasselgren PO
Arch Surg; 1997 Dec; 132(12):1289-93. PubMed ID: 9403532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
